Give megs a break: minor DNA stress, platelets in excess

In this issue of Blood Advances, Camacho et al 1 report that moderate DNA damage enhances megakaryopoiesis and platelet production in mice, providing the first evidence that direct DNA damage can influence megakaryocyte biology.To induce DNA damage, Camacho et al relied on niraparib, an US Food and Drug Administrationapproved poly (ADP-ribose) polymerase (PARP)1/2 inhibitor used to treat ovarian, fallopian tube, and primary peritoneal cancers.Niraparib prevents PARP-dependent recruitment of DNA repair effectors, thereby promoting the accumulation of DNA double-strand breaks. 2 In their study, the authors began by comparing the effects of high (50 mg/kg) and low (25 mg/kg) intraperitoneal doses of niraparib in mice.After 1 week of treatment, mice that received high doses of niraparib developed severe anemia and thrombocytopenia, an observation that mimics the adverse effects reported in some patients. 3Interestingly, low-dose treatment also led to progressive anemia, but this time resulted in mild thrombocytosis.This result was confirmed using another structurally unrelated PARP1/2 inhibitor and was reversible, with no effect on downstream platelet functions.To understand how low doses of niraparib increased platelet counts, Camacho et al performed a detailed analysis of the hematopoietic tree in the bone marrow of treated mice using flow cytometry.This analysis revealed a significant expansion in the number of long-term hematopoietic stem cells (HSC), multipotent progenitor 2 (MPP), megakarycotytic progenitors (MkPs), and megakaryocytes.This expansion was accompanied by clear evidence of DNA damage, as shown by comet assays and the accumulation of phosphorylated H2Ax across most analyzed populations.To assess whether these changes reflected PARP1/2-specific effects or represented a general response to DNA damage, the authors exposed cells to low-dose ionizing radiation (<200 cGy).Similar results were obtained, indicating that DNA damage, rather than PARP-specific inhibition, was the underlying cause.

Authors

Institutions

Publication Details

Journal
Blood Advances
Published
2026-01-05
DOI
https://doi.org/10.1182/bloodadvances.2025018294
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Give megs a break: minor DNA stress, platelets in excess

Quentin Kimmerlin, Catherine Strassel
Blood Advances
Platelet Disorders and Treatments
article

Give megs a break: minor DNA stress, platelets in excess

Quentin Kimmerlin, Catherine Strassel
article en

Abstract

In this issue of Blood Advances, Camacho et al 1 report that moderate DNA damage enhances megakaryopoiesis and platelet production in mice, providing the first evidence that direct DNA damage can influence megakaryocyte biology.To induce DNA damage, Camacho et al relied on niraparib, an US Food and Drug Administrationapproved poly (ADP-ribose) polymerase (PARP)1/2 inhibitor used to treat ovarian, fallopian tube, and primary peritoneal cancers.Niraparib prevents PARP-dependent recruitment of DNA repair effectors, thereby promoting the accumulation of DNA double-strand breaks. 2 In their study, the authors began by comparing the effects of high (50 mg/kg) and low (25 mg/kg) intraperitoneal doses of niraparib in mice.After 1 week of treatment, mice that received high doses of niraparib developed severe anemia and thrombocytopenia, an observation that mimics the adverse effects reported in some patients. 3Interestingly, low-dose treatment also led to progressive anemia, but this time resulted in mild thrombocytosis.This result was confirmed using another structurally unrelated PARP1/2 inhibitor and was reversible, with no effect on downstream platelet functions.To understand how low doses of niraparib increased platelet counts, Camacho et al performed a detailed analysis of the hematopoietic tree in the bone marrow of treated mice using flow cytometry.This analysis revealed a significant expansion in the number of long-term hematopoietic stem cells (HSC), multipotent progenitor 2 (MPP), megakarycotytic progenitors (MkPs), and megakaryocytes.This expansion was accompanied by clear evidence of DNA damage, as shown by comet assays and the accumulation of phosphorylated H2Ax across most analyzed populations.To assess whether these changes reflected PARP1/2-specific effects or represented a general response to DNA damage, the authors exposed cells to low-dose ionizing radiation (<200 cGy).Similar results were obtained, indicating that DNA damage, rather than PARP-specific inhibition, was the underlying cause.

Blood AdvancesVol. 10(1)
Inserm (FR), University of Basel (CH), University Hospital of Basel (CH), Établissement Français du Sang (FR)
Gender equality
Openalex Percentile: Top 98%
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.